CN113684166A - 一种高效合成软骨素寡聚糖的重组谷氨酸棒杆菌 - Google Patents

一种高效合成软骨素寡聚糖的重组谷氨酸棒杆菌 Download PDF

Info

Publication number
CN113684166A
CN113684166A CN202110926226.4A CN202110926226A CN113684166A CN 113684166 A CN113684166 A CN 113684166A CN 202110926226 A CN202110926226 A CN 202110926226A CN 113684166 A CN113684166 A CN 113684166A
Authority
CN
China
Prior art keywords
leu
chondroitin
lys
asn
ile
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202110926226.4A
Other languages
English (en)
Other versions
CN113684166B (zh
Inventor
康振
王阳
胡立涛
陈坚
堵国成
刘京京
孙婕妤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jiangnan University
Original Assignee
Jiangnan University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiangnan University filed Critical Jiangnan University
Priority to CN202110926226.4A priority Critical patent/CN113684166B/zh
Publication of CN113684166A publication Critical patent/CN113684166A/zh
Application granted granted Critical
Publication of CN113684166B publication Critical patent/CN113684166B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/1048Glycosyltransferases (2.4)
    • C12N9/1051Hexosyltransferases (2.4.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88Lyases (4.)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/04Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y302/00Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01183UDP-N-acetylglucosamine 2-epimerase (hydrolysing) (3.2.1.183)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y402/00Carbon-oxygen lyases (4.2)
    • C12Y402/02Carbon-oxygen lyases (4.2) acting on polysaccharides (4.2.2)
    • C12Y402/0202Chondroitin-sulfate-ABC endolyase (4.2.2.20)
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

本发明公开了一种高效合成软骨素及其寡聚糖的重组谷氨酸棒杆菌,属于生物工程技术领域。本发明构建的重组谷氨酸棒杆菌生产的软骨素寡聚糖的产量达到20g L‑1。通过构建软骨素合成途径并异源表达软骨素裂解酶,可以直接一步法发酵获得软骨素寡聚糖。本发明为微生物高效合成高纯度软骨素奠定了坚实的基础,构建的重组谷氨酸棒杆菌适合于工业化生产应用。

Description

一种高效合成软骨素寡聚糖的重组谷氨酸棒杆菌
技术领域
本发明涉及一种高效合成软骨素寡聚糖的重组谷氨酸棒杆菌,属于生物工程技术领域。
背景技术
硫酸软骨素是由葡萄糖醛酸和N-乙酰半乳糖胺为二糖单位聚合而成并经过一定程度修饰的直链酸性黏多糖。硫酸软骨素具有较好的粘弹性,保湿性和抑制炎性,还具有止痛、促进软骨再生等作用而被广泛应用于医药和保健品领域。高分子量软骨素具有良好的保湿、润滑的作用,可被用于医药领域。软骨素寡聚糖能够高效地被机体吸收,从而维护关节促进修复,而被用于口服保健品领域。
目前市场上的硫酸软骨素主要通过动物组织提取获得,但利用动物组织提取法提取硫酸软骨素存在许多缺点,首先组织提取法提取工艺复杂、步骤繁琐且最终获取产品纯度低,而产品的纯度直接影响产品的质量,低纯度的样品很难达到医药水平的要求。其次组织提取原材料为动物组织,存在原料来源限制问题且不同批次不同来源的组织,提取获得的样品分子量大小、修饰位点、修饰程度都存在差异,因此动物提取法获得的硫酸软骨素存在产品均一性问题。低分子量硫酸软骨素能够更好的被机体所吸收、利用,且功能更全面、高效。而组织提取获得的主要为高分子量的硫酸软骨素,获取寡聚糖还需要通过物理化学法和酶法等手段进一步处理才能获取,提高了产品制备的难度和成本。
为了解决上述的问题,人们希望利用基因工程技术在一些工程菌株中构建软骨素的合成途径获取软骨素,然后利用体外酶法催化获取专一、高纯度的硫酸软骨素。
发明内容
[技术问题]
本发明要解决的技术问题是如何利用微生物一步合成软骨素寡糖。
[技术方案]
本发明在谷氨酸棒杆菌中引入软骨素的合成途径,并在此基础上引入软骨素裂解酶,从而获得能够一步法生产软骨素寡聚糖的重组菌株。
本发明提供一种用于合成软骨素寡糖的重组谷氨酸棒杆菌,该重组谷氨酸棒杆菌异源表达软骨素合酶,并异源表达能够降解软骨素分子的软骨素裂解酶,所述软骨素合酶为(a)、(b)或(c)所示:
(a)来源于大肠杆菌(Escherichia coli K4)的软骨素合酶KfoC(SEQ ID NO.1),或与其有60%以上同源性的软骨素合酶;
(b)来源于多杀巴斯德杆菌(P.multocida)pmCS(SEQ ID NO.2),或与其有60%以上同源性的酶;
(c)含有SEQ ID NO.1和SEQ ID NO.2所示氨基酸序列的酶;
(d)在(a)或(b)中经过取代或缺失且具有软骨素合酶活性的由(a)或(b)衍生的蛋白质。
在一种实施方式中,所述重组谷氨酸棒杆菌还重组表达N-乙酰葡萄糖胺差向异构酶,催化UDP-葡萄糖胺合成UDP-半乳糖胺,从而促进软骨素合成。所述葡萄糖胺差向异构酶来源于大肠杆菌(E.coli K4),氨基酸序列如SEQ ID NO.3所示。
在一种实施方式中,所述重组谷氨酸棒杆菌还强化了前体物质UDP-N-乙酰半乳糖糖胺和/或UDP-葡萄糖醛酸的合成,包括强化pgM、ugdA、galU、glmS、glmM、glmU中一个或多个基因的表达。所述强化了前体物质UDP-N-乙酰半乳糖糖胺和/或UDP-葡萄糖醛酸合成,包括过对谷氨酰胺-果糖-6-磷酸氨基转移酶、磷酸葡萄糖变位酶、UDP-N-乙酰葡萄糖胺焦磷酸化酶/葡萄糖-1-磷酸乙酰转移酶双功能酶、磷酸葡萄糖变构酶、葡萄糖-6-磷酸尿酰胺转移酶、UDP-葡萄糖脱氢酶的基因进行过表达。所述磷酸葡萄糖变位酶PgM(NCBI referencesequence:WP_038674316.1),葡萄糖-6-磷酸尿酰胺转移酶GalU(NCBI referencesequence:WP_012677300.1),UDP-葡萄糖脱氢酶UgdA(NCBI reference sequence:WP_012677300.1),谷氨酰胺-果糖-6-磷酸氨基转移酶GlmS(NCBI reference sequence:WP_012514860.1),磷酸葡萄糖变构酶GlmM(NCBI reference sequence:WP_012677779.1),UDP-N-乙酰葡萄糖胺焦磷酸化酶/葡萄糖-1-磷酸乙酰转移酶双功能酶GlmU(NCBIreference sequence:WP_012677301.1)来源于兽疫链球菌(Streptococcus equi)。
在一种实施方式中,所述谷氨酸棒杆菌是在异源表达软骨素合酶基因和N-乙酰葡萄糖胺差向异构酶基因的基础上,通过构建表达框强化途径基因pgM、ugd、galU、glms、glmM和glmU的表达,从而加强软骨素的合成底物——UDP-N-乙酰半乳糖胺和UDP-葡萄糖醛酸的合成。
在一种实施方式中,所述软骨素裂解酶ChaseABC的氨基酸序列如SEQ ID NO.4所示。所述软骨素裂解酶的N端还添加氨基酸序列如SEQ ID NO.5所示的麦芽糖促溶标签(MBP),同时,还可以对N端的前5个氨基酸进行截短突变以提升蛋白的可溶性表达,并且通过选择具有不同结合能力的RBS序列(SEQ ID NO.6:AAAGGGTTCATAG、SEQ ID NO.7:AAAGGAGTTGCTT、SEQ ID NO.8:AAAGGTGGTTCAT、SEQ ID NO.9:AAAGGGGAGAGCC、SEQ IDNO.10:AAAGGCATGTTCT、SEQ ID NO.11:AAAGGCATGGCCG)来对软骨素裂解酶的表达量进行精细调控,最终实现软骨素寡聚糖的高效合成。
本发明的第二个目的是提供一种利用所述重组谷氨酸棒杆菌生产软骨素寡聚糖及其衍生产品方面的方法,包括以下步骤:
将重组谷氨酸棒杆菌经活化培养后,制成种子液,然后将种子液接种于装有发酵培养基的发酵罐中进行发酵培养,使重组谷氨酸棒杆菌以葡萄糖为底物合成软骨素寡聚糖,发酵过程中,将发酵液的pH控制在6.5-7之间,发酵培养基中葡萄糖含量控制在10g L-1附近。
[有益效果]
本发明在工业安全菌株谷氨酸棒杆菌(C.glutamicum)中异源表达来源于大肠杆菌或多杀巴斯德杆菌来源的软骨素合酶和葡萄糖胺差向异构酶,构建了软骨素的合成途径。通过构建表达框强化途径基因pgM,ugd,galU,glms,glmM,glmU的表达,加强软骨素的前体物质UDP-N-乙酰半乳糖胺和UDP-葡萄糖醛酸的合成,以解决软骨素合成过程中底物供应不足的问题,从而强化重组谷氨酸棒杆菌软骨素的合成能力。在其基础上表达软骨素裂解酶,实现软骨素寡聚糖的一步法生产,最终软骨素寡聚糖的生产能力达到20gL-1,是目前首次报道通过一步法实现合成软骨素寡聚糖。
附图说明
图1:重组谷氨酸棒杆菌生产软骨素的代谢途径及相关的酶类。
图2:软骨素裂解酶的表达优化;1,未改造的软骨素裂解酶;2,在软骨素裂解酶的N端融合MBP;3,在软骨素裂解酶的N端融合MBP的基础上,对N端进行截断改造。
图3:不同RBS序列对软骨素寡糖产量的影响。
图4:重组谷氨酸棒杆菌生产的软骨素寡聚糖的质谱图。
图5:重组谷氨酸棒杆菌的软骨素寡聚糖的5L发酵罐产量图。
具体实施方式
菌株、载体:谷氨酸棒杆菌(C.glutamicum ATCC 13032)、pK18mobSacB
LB培养基:酵母粉5g L-1,蛋白胨10g L-1,氯化钠10g L-1
BHI培养基:脑心浸出液37g L-1,山梨醇91g L-1
发酵培养基:葡萄糖:40g L-1,玉米浆干粉:20g/L,(NH4)2SO4:20g L-1,KH2PO4:1gL-1,K2HPO4:1g L-1,MgSO4:25g L-1,MOPS(3-吗啉丙磺酸):42g L-1
软骨素寡聚糖样品的制备:
取适当发酵液,10000xg离心10min取上清,加4倍体积的预冷乙醇,放入-20℃冰箱醇沉6h,10000xg离心10min弃沉淀,上清冷冻干燥加水复溶,10000xg离心10min取上清,弃沉淀,并加4倍体积的预冷乙醇,重复上述步骤三次。将获得的样品,加水复溶,待测定软骨素寡聚糖含量时,根据标准曲线的线性有效范围稀释样品,然后通过硫酸咔挫法测定产量。
软骨素寡聚糖含量的检测计算:
硫酸咔唑法进行测定:向装有5mL硼砂硫酸(500mL浓H2SO4中溶解4.77g硼砂)的玻璃管中加入1mL样品,左右轻微晃动混匀后在沸水浴中加热15min后,放置冰上冷却。并缓缓加入250μL咔唑试剂(100mL无水乙醇中溶解0.125g咔唑),混匀后沸水浴中再煮10min,对照为相同条件下的野生型谷氨酸棒杆菌发酵液。处理结束后测定样品在紫外530nm处的吸光值。分别用不同浓度(0、l0、20、30、40、50μg mL-1)的葡萄糖醛酸标准品作为标准曲线,最后将样品的吸光值带入标准曲线,计算出软骨素寡聚糖的含量。
标准曲线方程:y=126.88x-9.2639,R2=0.9991(x:吸光度A530;y:样品中葡萄糖醛酸含量(μg mL-1))。软骨素寡聚糖产量计算公式:软骨素寡聚糖含量(g/L)=(标准曲线测出的浓度*稀释倍数*2.067)/1000。
软骨素寡聚糖的LC-MS测定:
发酵上清,通过反复已醇溶解去除杂质,获得较高纯度的软骨素寡聚糖,然后在样品中加入9倍体积的无水甲醇,离心去除杂质后,经过有机膜过滤除去不溶杂质后,通过液相质谱联用LC-MS分析二糖单位的结构。
实施例1:重组谷氨酸棒杆菌的构建
(1)软骨素合酶基因的整合
提取谷氨酸棒杆菌(ATCC 13032)的基因组DNA,并将其作为模板,以U-up-F、U-up-R和D-down-F、D-down-R为引物进行PCR,扩增整合位点(乳酸脱氢酶基因)上下游1000bp长度的片段U-up和D-down并进行PCR产物纯化;
合成编码软骨素合酶的基因序列KfoC(SEQ ID NO.1)和编码N-乙酰葡萄糖胺差向异构酶KfoA的基因序列(SEQ ID NO.3),以KfoC-F、KfoC-R和KfoA-F和KfoC-R为引物进行PCR扩增,并进行PCR产物纯化;
将质粒pK18mobsacB使用EcoRI/BamhI进行酶切反应,用Gibson Assembly试剂盒将U-up、D-down、KfoC和KfoA四个基因片段连接到质粒pK18mobsacB上,获得的重组质粒将其命名为pK18-KfoC-KfoA;
采用电穿孔仪将质粒pK18-KfoC-KfoA通过电转化转入到谷氨酸棒杆菌(ATCC13032)中,电击条件为电压1.5KV,5ms(电击杯宽度为1mm),电击两次后加入预热的培养基46℃热激6min。30℃摇床后培养2h,涂板至含卡那霉素BHI平板上进行重组菌的第一次筛选。挑取阳性重组子进一步在液体BHI培养基里过夜培养,然后在含有100g L-1的蔗糖BHI平板上进行二次筛选。利用U-up-F和D-down-R为引物进行菌落PCR,菌落PCR验证大小正确的重组子进行测序验证,并将重组菌命名为C.glutamicum-KfoC-KfoA。
U-up-F:CGACGGCCAGTGCCAAGCTTACAGCCAGGTTAGCAGCCGT(SEQ ID NO.12)
U-up-R:GTTAATTGCTTGATTTAAGATAGACATGAGGACAATCTTGTTACCGACG(SEQ IDNO.13)
KfoC-F:CGTCGGTAACAAGATTGTCCTCATGTCTATCTTAAATCAAGCAATTAAC(SEQ IDNO.14)
KfoC-R:CGTGACCAGGATGTTCATTTACAAATCGTTTTCGATTTTCTCC(SEQ ID NO.15)
KfoA-F:AGAAAATCGAAAACGATTTGTAAATGAACATCCTGGTCACGG(SEQ ID NO.16)
KfoA-R:GCGCAGGGTATTTGCGGTTAAATGTACCCGTTAGGGTTTTTCATC(SEQ ID NO.17)
D-down-F:GGAGAAAATCGAAAACGATTTGTAAATTCCGCAAATACCCTGCGC(SEQ ID NO.18)
D-down-R:CTATGACCATGATTACGAATTCTCGTCGAGAATCTCATCGGC(SEQ ID NO.19)
(2)前体物质UDP-N-乙酰半乳糖糖胺和/或UDP-葡萄糖醛酸的合成途径的表达
S.equi subsp.zooepidimicu接种于5mL LB液体培养基,在37℃200rpm培养24h,收集菌体,并通过细胞基因组提取试剂盒提取基因组DNA。设计引物PgM-F/PgM-R,galU-F/galU-R,glmU-F/glmU-R,ugd-F/ugd-R,glmM-F/glmM-R和glmS-F/glmS-R,并以提取的基因组DNA为模板,通过PCR扩增获取pgM、galU、glmU、ugd、glmM和glmS的基因。并以谷氨酸棒杆菌基因组为模板,以cUP-F/cUP-R和cdown-F/cdown-R为引物进行PCR从而获得片段cUP和cDown。
将质粒pK18mobsacB使用EcoRI/BamhI进行酶切反应,用Gibson Assembly试剂盒将pgM、galU、glmU、ugd、glmM、glmS、cUP和cDown基因片段连接到质粒pK18mobsacB上,获得的重组质粒将其命名为pK18-GUD。将pK18-GUD转化将大肠杆菌JM109感受态细胞,取阳性转化子进行质粒测序,与序列比对,确认重组质粒pK18-GUD构建成功。利用电穿孔仪将质粒pK18-GUD通过电转化转入到步骤(1)构建的重组谷氨酸棒杆菌(C.glutamicum-KfoC-KfoA)中,电击条件为电压1.5KV,5ms(电击杯宽度为1mm)。通过筛选和PCR扩增基因片段进行测序等方式,获得正确的重组菌株C.glutamicum-CNA。
Galu-F:AAGGAGCGTATATCATGACAAAGGTCAGAAAAGCCATT(SEQ ID NO.20)
Galu-R:CATGATATACGCTCCTTATTTCTTGACGTCCTTGTTCAGTTG(SEQ ID NO.21)
PgM-F:AAGGAGCGTATATCATGACGCTCAGTCCTTTGGCAGG(SEQ ID NO.22)
PgM-R:CATGATATACGCTCCTTCTtcaggcaatggcttcatcgacc(SEQ ID NO.23)
GlmU-F:AAGGAGCGTATATCATGAAAAACTACGCCATTATCCTAG(SEQ ID NO.24)
GlmU-R:CATGATATACGCTCCTTCTAGGCTTGATTTGGGTGATGTG(SEQ ID NO.25)
Ugd-F:AAGGAGCGTATATCGTGAAAATTTCTGTAGCAGGC(SEQ ID NO.26)
Ugd-R:CATGATATACGCTCCTTCTAGTCTCTTCCAAAGACATCTCT(SEQ ID NO.27)
GlmM-F:AAGGAGCGTATATCATGGGAAAATATTTTGGAACGGATG(SEQ ID NO.28)
GlmM-R:CATGATATACGCTCCTTTTAATCAAGGCCAATTTCCGCACG(SEQ ID NO.29)
GlmS-F:AAGGAGCGTATATCATGTGTGGAATTGTTGGAGTTGTAG(SEQ ID NO.30)
GlmS-R:GCGCAGGGTATTTGCGGAATTTTACTCAACTGTAACAGCCTTGGC(SEQ ID NO.31)
Cup-F:CGACGGCCAGTGCCAAGCTTACAGCCAGGTTAGCAGCCGT(SEQ ID NO.32)
Cup-R:CATGATATACGCTCCTTGAGGACAATCTTGTTACCGACG(SEQ ID NO.33)
CDown-F:CGTCGGTAACAAGATTGTCCTCAATTCCGCAAATACCCTGCGC(SEQ ID NO.34)
CDown-R:CTATGACCATGATTACGAATTCTCGTCGAGAATCTCATCGGC(SEQ ID NO.35)
(3)软骨素裂解酶基因的表达
按照现有技术报道的序列,在金唯智(GENEWIZ)合成软骨素裂解酶基因序列,并通过引物Chase-F/Chase-R扩增软骨素裂解酶基因片段,并将其连接至质粒pECXK99E上,获得重组质粒pEC-chase。
在重组质粒pEC-chase的基础上,通过引物MBP-F/MBP-R扩增编码MBP蛋白的序列,然后与裂解酶基因序列连接,获得重组质粒pEC-MBP-chase,从而使裂解酶N端融合麦芽糖结合蛋白(MBP:理论分子量为42.0kDa)。同时,由于裂解酶N端序列的改变也会在翻译水平上影响目的蛋白的总表达水平,我们通过引物Del2-5-F/Del2-5-R在重组质粒pEC-MBP-chase的基础上,对裂解酶N端的前五个氨基酸进行截短,获得重组质粒pEC-MBP-N5chase。
利用电穿孔仪将上述重组质粒通过电转化转入到谷氨酸棒杆菌C.glutamicum,电击条件为电压1.5KV,5ms(电击杯宽度为1mm)。通过筛选和PCR扩增基因片段进行测序等方式,获得正确的重组菌株。将上述重组菌株,挑选单克隆接种于BHI液体培养基中,在200rpm,30℃的条件下培养10h后,并按2%的接种量转接于250mL装有发酵培养基的三角摇瓶中,在200rpm,28℃条件下培养,培养时长为24h,收集超声破碎,并进行SDS-PAGE凝胶电泳实验。结果如图2所示(1,未改造的软骨素裂解酶;2,在软骨素裂解酶的N端融合MBP;3,在软骨素裂解酶的N端融合MBP的基础上,对N端进行截断改造),通过蛋白胶图我们可以发现,N端融合MBP标签和N端序列改造显著提高了csABC I的可溶表达量。
软骨素裂解酶的表达强弱对,软骨素寡聚糖的合成至关重要。因此我们通过在MBP蛋白基因前,设计不同强弱的RBS序列(AAAGGGTTCATAG、AAAGGAGTTGCTT、AAAGGTGGTTCAT、AAAGGGGAGAGCC、AAAGGCATGTTCT、AAAGGCATGGCCG)从而调控软骨素裂解酶的表达强弱。以重组质粒pEC-MBP-N5chase为模板,分别利用引物RBS1-F,RBS2-F,RBS3-F,RBS4-F,RBS5-F,RBS6-F和RBS-R对重组质粒进行PCR扩增,从而获得重组质粒RBS1,RBS2,RBS3,RBS4,RBS5和RBS6。利用电穿孔仪将上述重组质粒通过电转化转入到重组谷氨酸棒杆菌C.glutamicum-CNA中,电击条件为电压1.5KV,5ms(电击杯宽度为1mm)。通过筛选和PCR扩增基因片段进行测序等方式,获得正确的重组菌株CGRBS1,CGRBS2,CGRBS3,CGRBS4,CGRBS5和CGRBS6。
Chase-F:CTCGGTACCCGGGGATCCAAGGAGCGTATATCATGACTGCACTTGCAATGACATTG(SEQID NO.36)
Chase-R:CAAGCTTGCATGCCTGCAGTCAAGGGAGTGGCGAGAG(SEQ ID NO.37)
MBP-F:CTCGGTACCCGGGGATCCATGAAAATCGAAGAAGGTAAACTGG(SEQ ID NO.38)
MBP-R:GCAGTAAAACGAAATATCGGCATAGTCTGCGCGTCTTTCAGG(SEQ ID NO.39)
Del2-5-F:TTTACTGCACTTGCAATGACAT(SEQ ID NO.40)
Del2-5-R:ATGTCATTGCAAGTGCAGTAAATAGTCTGCGCGTCTTTCAGG(SEQ ID NO.41)
RBS1-F:CTCGGTACCCGGGGATCCAAAGGGTTCATAGATGAAAATCGAAGAAGGTAA(SEQ IDNO.42)
RBS2-F:CTCGGTACCCGGGGATCCAAAGGAGTTGCTTATGAAAATCGAAGAAGGTAA(SEQ IDNO.43)
RBS3-F:CTCGGTACCCGGGGATCCAAAGGTGGTTCATATGAAAATCGAAGAAGGTAA(SEQ IDNO.44)
RBS4-F:CTCGGTACCCGGGGATCCAAAGGGGAGAGCCATGAAAATCGAAGAAGGTAA(SEQ IDNO.45)
RBS5-F:CTCGGTACCCGGGGATCCAAAGGCATGTTCTATGAAAATCGAAGAAGGTAA(SEQ IDNO.46)
RBS6-F:CTCGGTACCCGGGGATCCAAAGGCATGGCCGATGAAAATCGAAGAAGGTAA(SEQ IDNO.47)
RBS-R:GGATCCCCGGGTACCGAG(SEQ ID NO.48)
实施例2:利用重组谷氨酸棒杆菌生产软骨素寡聚糖
将实施例1构建的重组谷氨酸棒杆菌CGRBS1、CGRBS2、CGRBS3、CGRBS4、CGRBS5和CGRBS6在平板上活化,挑选单克隆接种于BHI液体培养基中,在200rpm,30℃的条件下培养10h后,并按2%的接种量转接于250mL装有发酵培养基的三角摇瓶中,在200rpm,28℃条件下培养,培养时长为48h。
发酵结束后收集上清,在上清中加入4倍体积的乙醇进行醇沉,去沉淀,将上清进行干燥。取干燥后固体加水溶解,去除不溶物,并重复上述操作三后进行收集。纯化后的样品通过硫酸咔唑法对软骨素寡聚糖含量进行测定,结果如图3所示,通过RBS序列的优化,摇瓶发酵软骨素寡聚糖产量最高达到1.1g L-1(重组菌株CGRBS6)。纯化后的样品通过LC-MS-IT-TOF对分子结构进行鉴定,结果如图4所示。
实施例3:重组谷氨酸棒杆菌的5L发酵罐发酵培养
将实施例1构建的重组谷氨酸棒杆菌重组菌株CGRBS6在平板上活化,挑选单克隆接种于BHI液体培养基中,在200rpm,30℃的条件下培养10h后,并按2%的接种量转接于250mL三角摇瓶中,在200rpm、30℃条件下培养8h,然后以10%的接种量接种于5L发酵罐中,发酵培养基的装液量为1.5L,温度为30℃,搅拌转速为500rpm,通气量为5vv min,发酵过程中,通过流加14%的氨水,将发酵液的pH控制在6.5-7之间,通过流加500g L-1的葡萄糖溶液维持发酵液环境中葡萄糖含量在10g L-1附近,以维持菌株正常的生长所需,并在20h时添加0.1mM的氨苄青霉素。从图5可以看出,软骨素寡聚糖的产量在48h时最高达到20g L-1
SEQUENCE LISTING
<110> 江南大学
<120> 一种高效合成软骨素寡聚糖的重组谷氨酸棒杆菌
<130> BAA210253A
<160> 48
<170> PatentIn version 3.3
<210> 1
<211> 686
<212> PRT
<213> Escherichia coli K4
<400> 1
Met Ser Ile Leu Asn Gln Ala Ile Asn Leu Tyr Lys Asn Lys Asn Tyr
1 5 10 15
Arg Gln Ala Leu Ser Leu Phe Glu Lys Val Ala Glu Ile Tyr Asp Val
20 25 30
Ser Trp Val Glu Ala Asn Ile Lys Leu Cys Gln Thr Ala Leu Asn Leu
35 40 45
Ser Glu Glu Val Asp Lys Leu Asn Arg Lys Ala Val Ile Asp Ile Asp
50 55 60
Ala Ala Thr Lys Ile Met Cys Ser Asn Ala Lys Ala Ile Ser Leu Asn
65 70 75 80
Glu Val Glu Lys Asn Glu Ile Ile Ser Lys Tyr Arg Glu Ile Thr Ala
85 90 95
Lys Lys Ser Glu Arg Ala Glu Leu Lys Glu Val Glu Pro Ile Pro Leu
100 105 110
Asp Trp Pro Ser Asp Leu Thr Leu Pro Pro Leu Pro Glu Ser Thr Asn
115 120 125
Asp Tyr Val Trp Ala Gly Lys Arg Lys Glu Leu Asp Asp Tyr Pro Arg
130 135 140
Lys Gln Leu Ile Ile Asp Gly Leu Ser Ile Val Ile Pro Thr Tyr Asn
145 150 155 160
Arg Ala Lys Ile Leu Ala Ile Thr Leu Ala Cys Leu Cys Asn Gln Lys
165 170 175
Thr Ile Tyr Asp Tyr Glu Val Ile Val Ala Asp Asp Gly Ser Lys Glu
180 185 190
Asn Ile Glu Glu Ile Val Arg Glu Phe Glu Ser Leu Leu Asn Ile Lys
195 200 205
Tyr Val Arg Gln Lys Asp Tyr Gly Tyr Gln Leu Cys Ala Val Arg Asn
210 215 220
Leu Gly Leu Arg Ala Ala Lys Tyr Asn Tyr Val Ala Ile Leu Asp Cys
225 230 235 240
Asp Met Ala Pro Asn Pro Leu Trp Val Gln Ser Tyr Met Glu Leu Leu
245 250 255
Ala Val Asp Asp Asn Val Ala Leu Ile Gly Pro Arg Lys Tyr Ile Asp
260 265 270
Thr Ser Lys His Thr Tyr Leu Asp Phe Leu Ser Gln Lys Ser Leu Ile
275 280 285
Asn Glu Ile Pro Glu Ile Ile Thr Asn Asn Gln Val Ala Gly Lys Val
290 295 300
Glu Gln Asn Lys Ser Val Asp Trp Arg Ile Glu His Phe Lys Asn Thr
305 310 315 320
Asp Asn Leu Arg Leu Cys Asn Thr Pro Phe Arg Phe Phe Ser Gly Gly
325 330 335
Asn Val Ala Phe Ala Lys Lys Trp Leu Phe Arg Ala Gly Trp Phe Asp
340 345 350
Glu Glu Phe Thr His Trp Gly Gly Glu Asp Asn Glu Phe Gly Tyr Arg
355 360 365
Leu Tyr Arg Glu Gly Cys Tyr Phe Arg Ser Val Glu Gly Ala Met Ala
370 375 380
Tyr His Gln Glu Pro Pro Gly Lys Glu Asn Glu Thr Asp Arg Ala Ala
385 390 395 400
Gly Lys Asn Ile Thr Val Gln Leu Leu Gln Gln Lys Val Pro Tyr Phe
405 410 415
Tyr Arg Lys Lys Glu Lys Ile Glu Ser Ala Thr Leu Lys Arg Val Pro
420 425 430
Leu Val Ser Ile Tyr Ile Pro Ala Tyr Asn Cys Ser Lys Tyr Ile Val
435 440 445
Arg Cys Val Glu Ser Ala Leu Asn Gln Thr Ile Thr Asp Leu Glu Val
450 455 460
Cys Ile Cys Asp Asp Gly Ser Thr Asp Asp Thr Leu Arg Ile Leu Gln
465 470 475 480
Glu His Tyr Ala Asn His Pro Arg Val Arg Phe Ile Ser Gln Lys Asn
485 490 495
Lys Gly Ile Gly Ser Ala Ser Asn Thr Ala Val Arg Leu Cys Arg Gly
500 505 510
Phe Tyr Ile Gly Gln Leu Asp Ser Asp Asp Phe Leu Glu Pro Asp Ala
515 520 525
Val Glu Leu Cys Leu Asp Glu Phe Arg Lys Asp Leu Ser Leu Ala Cys
530 535 540
Val Tyr Thr Thr Asn Arg Asn Ile Asp Arg Glu Gly Asn Leu Ile Ser
545 550 555 560
Asn Gly Tyr Asn Trp Pro Ile Tyr Ser Arg Glu Lys Leu Thr Ser Ala
565 570 575
Met Ile Cys His His Phe Arg Met Phe Thr Ala Arg Ala Trp Asn Leu
580 585 590
Thr Glu Gly Phe Asn Glu Ser Ile Ser Asn Ala Val Asp Tyr Asp Met
595 600 605
Tyr Leu Lys Leu Ser Glu Val Gly Pro Phe Lys His Ile Asn Lys Ile
610 615 620
Cys Tyr Asn Arg Val Leu His Gly Glu Asn Thr Ser Ile Lys Lys Leu
625 630 635 640
Asp Ile Gln Lys Glu Asn His Phe Lys Val Val Asn Glu Ser Leu Ser
645 650 655
Arg Leu Gly Ile Lys Lys Tyr Lys Tyr Ser Pro Leu Thr Asn Leu Asn
660 665 670
Glu Cys Arg Lys Tyr Thr Trp Glu Lys Ile Glu Asn Asp Leu
675 680 685
<210> 2
<211> 965
<212> PRT
<213> 多杀巴斯德杆菌
<400> 2
Met Asn Thr Leu Ser Gln Ala Ile Lys Ala Tyr Asn Ser Asn Asp Tyr
1 5 10 15
Glu Leu Ala Leu Lys Leu Phe Glu Lys Ser Ala Glu Thr Tyr Gly Arg
20 25 30
Lys Ile Val Glu Phe Gln Ile Ile Lys Cys Lys Glu Lys Leu Ser Thr
35 40 45
Asn Ser Tyr Val Ser Glu Asp Lys Lys Asn Ser Val Cys Asp Ser Ser
50 55 60
Leu Asp Ile Ala Thr Gln Leu Leu Leu Ser Asn Val Lys Lys Leu Thr
65 70 75 80
Leu Ser Glu Ser Glu Lys Asn Ser Leu Lys Asn Lys Trp Lys Ser Ile
85 90 95
Thr Gly Lys Lys Ser Glu Asn Ala Glu Ile Arg Lys Val Glu Leu Val
100 105 110
Pro Lys Asp Phe Pro Lys Asp Leu Val Leu Ala Pro Leu Pro Asp His
115 120 125
Val Asn Asp Phe Thr Trp Tyr Lys Asn Arg Lys Lys Ser Leu Gly Ile
130 135 140
Lys Pro Val Asn Lys Asn Ile Gly Leu Ser Ile Ile Ile Pro Thr Phe
145 150 155 160
Asn Arg Ser Arg Ile Leu Asp Ile Thr Leu Ala Cys Leu Val Asn Gln
165 170 175
Lys Thr Asn Tyr Pro Phe Glu Val Val Val Ala Asp Asp Gly Ser Lys
180 185 190
Glu Asn Leu Leu Thr Ile Val Gln Lys Tyr Glu Gln Lys Leu Asp Ile
195 200 205
Lys Tyr Val Arg Gln Lys Asp Tyr Gly Tyr Gln Leu Cys Ala Val Arg
210 215 220
Asn Leu Gly Leu Arg Thr Ala Lys Tyr Asp Phe Val Ser Ile Leu Asp
225 230 235 240
Cys Asp Met Ala Pro Gln Gln Leu Trp Val His Ser Tyr Leu Thr Glu
245 250 255
Leu Leu Glu Asp Asn Asp Ile Val Leu Ile Gly Pro Arg Lys Tyr Val
260 265 270
Asp Thr His Asn Ile Thr Ala Glu Gln Phe Leu Asn Asp Pro Tyr Leu
275 280 285
Ile Glu Ser Leu Pro Glu Thr Ala Thr Asn Asn Asn Pro Ser Ile Thr
290 295 300
Ser Lys Gly Asn Ile Ser Leu Asp Trp Arg Leu Glu His Phe Lys Lys
305 310 315 320
Thr Asp Asn Leu Arg Leu Cys Asp Ser Pro Phe Arg Tyr Phe Ser Cys
325 330 335
Gly Asn Val Ala Phe Ser Lys Glu Trp Leu Asn Lys Val Gly Trp Phe
340 345 350
Asp Glu Glu Phe Asn His Trp Gly Gly Glu Asp Val Glu Phe Gly Tyr
355 360 365
Arg Leu Phe Ala Lys Gly Cys Phe Phe Arg Val Ile Asp Gly Gly Met
370 375 380
Ala Tyr His Gln Glu Pro Pro Gly Lys Glu Asn Glu Thr Asp Arg Glu
385 390 395 400
Ala Gly Lys Ser Ile Thr Leu Lys Ile Val Lys Glu Lys Val Pro Tyr
405 410 415
Ile Tyr Arg Lys Leu Leu Pro Ile Glu Asp Ser His Ile His Arg Ile
420 425 430
Pro Leu Val Ser Ile Tyr Ile Pro Ala Tyr Asn Cys Ala Asn Tyr Ile
435 440 445
Gln Arg Cys Val Asp Ser Ala Leu Asn Gln Thr Val Val Asp Leu Glu
450 455 460
Val Cys Ile Cys Asn Asp Gly Ser Thr Asp Asn Thr Leu Glu Val Ile
465 470 475 480
Asn Lys Leu Tyr Gly Asn Asn Pro Arg Val Arg Ile Met Ser Lys Pro
485 490 495
Asn Gly Gly Ile Ala Ser Ala Ser Asn Ala Ala Val Ser Phe Ala Lys
500 505 510
Gly Tyr Tyr Ile Gly Gln Leu Asp Ser Asp Asp Tyr Leu Glu Pro Asp
515 520 525
Ala Val Glu Leu Cys Leu Lys Glu Phe Leu Lys Asp Lys Thr Leu Ala
530 535 540
Cys Val Tyr Thr Thr Asn Arg Asn Val Asn Pro Asp Gly Ser Leu Ile
545 550 555 560
Ala Asn Gly Tyr Asn Trp Pro Glu Phe Ser Arg Glu Lys Leu Thr Thr
565 570 575
Ala Met Ile Ala His His Phe Arg Met Phe Thr Ile Arg Ala Trp His
580 585 590
Leu Thr Asp Gly Phe Asn Glu Lys Ile Glu Asn Ala Val Asp Tyr Asp
595 600 605
Met Phe Leu Lys Leu Ser Glu Val Gly Lys Phe Lys His Leu Asn Lys
610 615 620
Ile Cys Tyr Asn Arg Val Leu His Gly Asp Asn Thr Ser Ile Lys Asn
625 630 635 640
Leu Asp Thr Gln Lys Lys Asn His Phe Val Val Val Asn Gln Ser Leu
645 650 655
Asn Arg Gln Arg Val Ser Asn Tyr Asn Tyr Asp Glu Phe Asp Asn Leu
660 665 670
Asp Glu Ser Arg Lys Tyr Ile Phe Asn Lys Thr Ala Asp Tyr Gln Glu
675 680 685
Glu Ile Asp Ile Leu Lys Asp Ile Lys Ile Val Gln Arg Lys Asp Ala
690 695 700
Lys Val Ala Ile Ser Ile Phe Tyr Pro Asn Arg Leu Asp Gly Leu Val
705 710 715 720
Lys Lys Leu Asn Asn Ile Ile Glu Tyr Asn Lys Asn Val Leu Ile Ile
725 730 735
Val Leu His Ile Asp Lys Asn His Leu Thr Ser Asp Ile Lys Lys Glu
740 745 750
Ile Leu Glu Phe His Asn Lys Asn Gln Ile Asn Ile Leu Leu Asn Asn
755 760 765
Asp Val Ser Tyr Tyr Thr Asn Asn Arg Leu Ile Lys Thr Lys Ala His
770 775 780
Leu Ser Asn Met Asn Lys Leu Arg Gln Leu Asn Leu Asn Leu Glu Tyr
785 790 795 800
Ile Ile Phe Asp Asn His Asp Ser Leu Phe Ile Lys Asn Asp Ser Tyr
805 810 815
Asn His Ile Lys Lys Tyr Asp Ile Gly Met Asn Phe Ser Ser Leu Thr
820 825 830
Asn Asp Trp Ile Asn Lys Ile Asn Ala His Ser Pro Phe Lys Asn Leu
835 840 845
Ile Lys Lys Tyr Phe Asn Asp Asn Asp Leu Lys Thr Ile Asn Met Lys
850 855 860
Gly Ala Ser Gln Gly Met Phe Ile Lys Tyr Thr Leu Ala His Asp Ile
865 870 875 880
Ala Thr Ile Met Lys Glu Val Ile Thr Leu Cys Gln Ser Thr Asp Ser
885 890 895
Val Pro Glu Tyr Asn Thr Glu Asp Ile Trp Phe Gln Phe Ala Leu Leu
900 905 910
Ile Leu Glu Lys Lys Thr Gly His Val Phe Asn Lys Thr Ser Thr Leu
915 920 925
Thr Tyr Met Pro Trp Glu Arg Lys Leu Gln Trp Thr Asn Glu Gln Ile
930 935 940
Glu Ser Ala Lys Arg Gly Glu Asn Ile Pro Val Asn Lys Phe Ile Ile
945 950 955 960
Asn Ser Ile Thr Leu
965
<210> 3
<211> 339
<212> PRT
<213> Escherichia coli K4
<400> 3
Met Asn Ile Leu Val Thr Gly Gly Ala Gly Tyr Ile Gly Ser His Thr
1 5 10 15
Ser Leu Cys Leu Leu Asn Lys Gly Tyr Asn Val Val Ile Ile Asp Asn
20 25 30
Leu Ile Asn Ser Ser Cys Glu Ser Ile Arg Arg Ile Glu Leu Ile Ala
35 40 45
Lys Lys Lys Val Thr Phe Tyr Glu Leu Asn Ile Asn Asn Glu Lys Glu
50 55 60
Val Asn Gln Ile Leu Lys Lys His Lys Phe Asp Cys Ile Met His Phe
65 70 75 80
Ala Gly Ala Lys Ser Val Ala Glu Ser Leu Ile Lys Pro Ile Phe Tyr
85 90 95
Tyr Asp Asn Asn Val Ser Gly Thr Leu Gln Leu Ile Asn Cys Ala Ile
100 105 110
Lys Asn Asp Val Ala Asn Phe Ile Phe Ser Ser Ser Ala Thr Val Tyr
115 120 125
Gly Glu Ser Lys Ile Met Pro Val Thr Glu Asp Cys His Ile Gly Gly
130 135 140
Thr Leu Asn Pro Tyr Gly Thr Ser Lys Tyr Ile Ser Glu Leu Met Ile
145 150 155 160
Arg Asp Ile Ala Lys Lys Tyr Ser Asp Thr Asn Phe Leu Cys Leu Arg
165 170 175
Tyr Phe Asn Pro Thr Gly Ala His Glu Ser Gly Met Ile Gly Glu Ser
180 185 190
Pro Ala Asp Ile Pro Ser Asn Leu Val Pro Tyr Ile Leu Gln Val Ala
195 200 205
Met Gly Lys Leu Glu Lys Leu Met Val Phe Gly Gly Asp Tyr Pro Thr
210 215 220
Lys Asp Gly Thr Gly Val Arg Asp Tyr Ile His Val Met Asp Leu Ala
225 230 235 240
Glu Gly His Val Ala Ala Leu Ser Tyr Leu Phe Arg Asp Asn Asn Thr
245 250 255
Asn Tyr His Val Phe Asn Leu Gly Thr Gly Lys Gly Tyr Ser Val Leu
260 265 270
Glu Leu Val Ser Thr Phe Glu Lys Ile Ser Gly Val Arg Ile Pro Tyr
275 280 285
Glu Ile Val Ser Arg Arg Asp Gly Asp Ile Ala Glu Ser Trp Ser Ser
290 295 300
Pro Glu Lys Ala Asn Lys Tyr Leu Asn Trp Lys Ala Lys Arg Glu Leu
305 310 315 320
Glu Thr Met Leu Glu Asp Ala Trp Arg Trp Gln Met Lys Asn Pro Asn
325 330 335
Gly Tyr Ile
<210> 4
<211> 1016
<212> PRT
<213> Proteus vulgaris
<400> 4
Met Thr Ala Leu Ala Met Thr Leu Gly Leu Leu Ser Ala Pro Tyr Asn
1 5 10 15
Ala Met Ala Ala Thr Ser Asn Pro Ala Phe Asp Pro Lys Asn Leu Met
20 25 30
Gln Ser Glu Ile Tyr His Phe Ala Gln Asn Asn Pro Leu Ala Asp Phe
35 40 45
Ser Ser Asp Lys Asn Ser Ile Leu Thr Leu Ser Asp Lys Arg Ser Ile
50 55 60
Met Gly Asn Gln Ser Leu Leu Trp Lys Trp Lys Gly Gly Ser Ser Phe
65 70 75 80
Thr Leu His Lys Lys Leu Ile Val Pro Thr Asp Lys Glu Ala Ser Lys
85 90 95
Ala Trp Gly Arg Ser Ser Thr Pro Val Phe Ser Phe Trp Leu Tyr Asn
100 105 110
Glu Lys Pro Ile Asp Gly Tyr Pro Thr Ile Asp Phe Gly Glu Lys Leu
115 120 125
Ile Ser Thr Ser Glu Ala Gln Ala Gly Phe Lys Val Lys Leu Asp Phe
130 135 140
Thr Gly Trp Arg Ala Val Gly Val Ser Leu Asn Asn Asp Leu Glu Asn
145 150 155 160
Arg Glu Met Thr Leu Asn Ala Thr Asn Thr Ser Ser Asp Gly Thr Gln
165 170 175
Asp Ser Ile Gly Arg Ser Leu Gly Ala Lys Val Asp Ser Ile Arg Phe
180 185 190
Lys Ala Pro Ser Asn Val Ser Gln Gly Glu Ile Tyr Ile Asp Arg Ile
195 200 205
Met Phe Ser Val Asp Asp Ala Arg Tyr Gln Trp Ser Asp Tyr Gln Val
210 215 220
Lys Thr Arg Leu Ser Glu Pro Glu Ile Gln Phe His Asn Val Lys Pro
225 230 235 240
Gln Leu Pro Val Thr Pro Glu Asn Leu Ala Ala Ile Asp Leu Ile Arg
245 250 255
Gln Arg Leu Ile Asn Glu Phe Val Gly Gly Glu Lys Glu Thr Asn Leu
260 265 270
Ala Leu Glu Glu Asn Ile Ser Lys Leu Lys Ser Asp Phe Asp Ala Leu
275 280 285
Asn Ile His Thr Leu Ala Asn Gly Gly Thr Gln Gly Arg His Leu Ile
290 295 300
Thr Asp Lys Gln Ile Ile Ile Tyr Gln Pro Glu Asn Leu Asn Ser Gln
305 310 315 320
Asp Lys Gln Leu Phe Asp Asn Tyr Val Ile Leu Gly Asn Tyr Thr Thr
325 330 335
Leu Met Phe Asn Ile Ser Arg Ala Tyr Val Leu Glu Lys Asp Pro Thr
340 345 350
Gln Lys Ala Gln Leu Lys Gln Met Tyr Leu Leu Val Thr Lys His Leu
355 360 365
Leu Asp Gln Gly Phe Val Lys Gly Ser Ala Leu Val Thr Thr His His
370 375 380
Trp Gly Tyr Ser Ser Arg Trp Trp Tyr Ile Ser Thr Leu Leu Met Ser
385 390 395 400
Asp Ala Leu Lys Glu Ala Asn Leu Gln Thr Gln Val Tyr Asp Ser Leu
405 410 415
Leu Trp Tyr Ser Arg Glu Phe Lys Ser Ser Phe Asp Met Lys Val Ser
420 425 430
Ala Asp Ser Ser Asp Leu Asp Tyr Phe Asn Thr Leu Ser Arg Gln His
435 440 445
Leu Ala Leu Leu Leu Leu Glu Pro Asp Asp Gln Lys Arg Ile Asn Leu
450 455 460
Val Asn Thr Phe Ser His Tyr Ile Thr Gly Ala Leu Thr Gln Val Pro
465 470 475 480
Pro Gly Gly Lys Asp Gly Leu Arg Leu Met Val Gln His Gly Asp Met
485 490 495
Lys Ala Thr Ile Arg Val Thr Leu Ser Gln Pro Leu Lys Met Pro Leu
500 505 510
Ser Leu Phe Ile Tyr Tyr Ala Ile His His Phe Gln Leu Gly Glu Ser
515 520 525
Gly Trp Asn Asn Leu Lys Lys Ala Met Val Ser Ala Trp Ile Tyr Ser
530 535 540
Asn Pro Glu Val Gly Leu Pro Leu Ala Gly Arg His Pro Phe Asn Ser
545 550 555 560
Pro Ser Leu Lys Ser Val Ala Gln Gly Tyr Tyr Trp Leu Ala Met Ser
565 570 575
Ala Lys Ser Ser Pro Asp Lys Thr Leu Ala Ser Ile Tyr Leu Ala Ile
580 585 590
Ser Asp Lys Thr Gln Asn Glu Ser Thr Ala Ile Phe Gly Glu Thr Ile
595 600 605
Thr Pro Ala Ser Leu Pro Gln Gly Phe Tyr Ala Phe Asn Gly Gly Ala
610 615 620
Phe Gly Ile His Arg Trp Gln Asp Lys Met Val Thr Leu Lys Ala Tyr
625 630 635 640
Asn Thr Asn Val Trp Ser Ser Glu Ile Tyr Asn Lys Asp Asn Arg Tyr
645 650 655
Gly Arg Tyr Gln Ser His Gly Val Gly Gln Ile Val Ser Asn Gly Ser
660 665 670
Gln Leu Ser Gln Gly Tyr Gln Gln Glu Gly Trp Asp Trp Asn Arg Met
675 680 685
Gln Gly Ala Thr Thr Ile His Leu Pro Leu Lys Asp Leu Asp Ser Pro
690 695 700
Lys Pro His Thr Leu Met Gln Arg Gly Glu Arg Gly Phe Ser Gly Thr
705 710 715 720
Ser Ser Leu Glu Gly Gln Tyr Gly Met Met Ala Phe Asp Leu Ile Tyr
725 730 735
Pro Ala Asn Leu Glu Arg Phe Asp Pro Asn Phe Thr Ala Lys Lys Ser
740 745 750
Val Leu Ala Ala Asp Asn His Leu Ile Phe Ile Gly Ser Asn Ile Asn
755 760 765
Ser Ser Asp Lys Asn Lys Asn Val Glu Thr Thr Leu Phe Gln His Ala
770 775 780
Ile Thr Pro Thr Leu Asn Thr Leu Trp Ile Asn Gly Gln Lys Ile Glu
785 790 795 800
Asn Met Pro Tyr Gln Thr Thr Leu Gln Gln Gly Asp Trp Leu Ile Asp
805 810 815
Ser Asn Gly Asn Gly Tyr Leu Ile Thr Gln Ala Glu Lys Val Asn Val
820 825 830
Ser Arg Gln His Gln Val Ser Ala Glu Asn Lys Asn Arg Gln Pro Thr
835 840 845
Glu Gly Asn Phe Ser Ser Ala Trp Ile Asp His Arg Thr Arg Pro Lys
850 855 860
Asp Ala Ser Tyr Glu Tyr Met Val Phe Leu Asp Ala Thr Pro Glu Lys
865 870 875 880
Met Gly Glu Met Ala Gln Lys Phe Arg Glu Asn Asn Gly Leu Tyr Gln
885 890 895
Val Leu Arg Lys Asp Lys Asp Val His Ile Ile Leu Asp Lys Leu Ser
900 905 910
Asn Val Thr Gly Tyr Ala Phe Tyr Gln Pro Ala Ser Ile Glu Asp Lys
915 920 925
Trp Ile Lys Lys Val Asn Lys Pro Ala Ile Val Met Thr His Arg Gln
930 935 940
Lys Asp Thr Leu Ile Val Ser Ala Val Thr Pro Asp Leu Asn Met Thr
945 950 955 960
Arg Gln Lys Ala Ala Thr Pro Val Thr Ile Asn Val Thr Ile Asn Gly
965 970 975
Lys Trp Gln Ser Ala Asp Lys Asn Ser Glu Val Lys Tyr Gln Val Ser
980 985 990
Gly Asp Asn Thr Glu Leu Thr Phe Thr Ser Tyr Phe Gly Ile Pro Gln
995 1000 1005
Glu Ile Lys Leu Ser Pro Leu Pro
1010 1015
<210> 5
<211> 367
<212> PRT
<213> Escherichia coli K12
<400> 5
Met Lys Ile Glu Glu Gly Lys Leu Val Ile Trp Ile Asn Gly Asp Lys
1 5 10 15
Gly Tyr Asn Gly Leu Ala Glu Val Gly Lys Lys Phe Glu Lys Asp Thr
20 25 30
Gly Ile Lys Val Thr Val Glu His Pro Asp Lys Leu Glu Glu Lys Phe
35 40 45
Pro Gln Val Ala Ala Thr Gly Asp Gly Pro Asp Ile Ile Phe Trp Ala
50 55 60
His Asp Arg Phe Gly Gly Tyr Ala Gln Ser Gly Leu Leu Ala Glu Ile
65 70 75 80
Thr Pro Asp Lys Ala Phe Gln Asp Lys Leu Tyr Pro Phe Thr Trp Asp
85 90 95
Ala Val Arg Tyr Asn Gly Lys Leu Ile Ala Tyr Pro Ile Ala Val Glu
100 105 110
Ala Leu Ser Leu Ile Tyr Asn Lys Asp Leu Leu Pro Asn Pro Pro Lys
115 120 125
Thr Trp Glu Glu Ile Pro Ala Leu Asp Lys Glu Leu Lys Ala Lys Gly
130 135 140
Lys Ser Ala Leu Met Phe Asn Leu Gln Glu Pro Tyr Phe Thr Trp Pro
145 150 155 160
Leu Ile Ala Ala Asp Gly Gly Tyr Ala Phe Lys Tyr Glu Asn Gly Lys
165 170 175
Tyr Asp Ile Lys Asp Val Gly Val Asp Asn Ala Gly Ala Lys Ala Gly
180 185 190
Leu Thr Phe Leu Val Asp Leu Ile Lys Asn Lys His Met Asn Ala Asp
195 200 205
Thr Asp Tyr Ser Ile Ala Glu Ala Ala Phe Asn Lys Gly Glu Thr Ala
210 215 220
Met Thr Ile Asn Gly Pro Trp Ala Trp Ser Asn Ile Asp Thr Ser Lys
225 230 235 240
Val Asn Tyr Gly Val Thr Val Leu Pro Thr Phe Lys Gly Gln Pro Ser
245 250 255
Lys Pro Phe Val Gly Val Leu Ser Ala Gly Ile Asn Ala Ala Ser Pro
260 265 270
Asn Lys Glu Leu Ala Lys Glu Phe Leu Glu Asn Tyr Leu Leu Thr Asp
275 280 285
Glu Gly Leu Glu Ala Val Asn Lys Asp Lys Pro Leu Gly Ala Val Ala
290 295 300
Leu Lys Ser Tyr Glu Glu Glu Leu Val Lys Asp Pro Arg Ile Ala Ala
305 310 315 320
Thr Met Glu Asn Ala Gln Lys Gly Glu Ile Met Pro Asn Ile Pro Gln
325 330 335
Met Ser Ala Phe Trp Tyr Ala Val Arg Thr Ala Val Ile Asn Ala Ala
340 345 350
Ser Gly Arg Gln Thr Val Asp Glu Ala Leu Lys Asp Ala Gln Thr
355 360 365
<210> 6
<211> 13
<212> DNA
<213> 人工序列
<400> 6
aaagggttca tag 13
<210> 7
<211> 13
<212> DNA
<213> 人工序列
<400> 7
aaaggagttg ctt 13
<210> 8
<211> 13
<212> DNA
<213> 人工序列
<400> 8
aaaggtggtt cat 13
<210> 9
<211> 13
<212> DNA
<213> 人工序列
<400> 9
aaaggggaga gcc 13
<210> 10
<211> 13
<212> DNA
<213> 人工序列
<400> 10
aaaggcatgt tct 13
<210> 11
<211> 13
<212> DNA
<213> 人工序列
<400> 11
aaaggcatgg ccg 13
<210> 12
<211> 40
<212> DNA
<213> 人工序列
<400> 12
cgacggccag tgccaagctt acagccaggt tagcagccgt 40
<210> 13
<211> 49
<212> DNA
<213> 人工序列
<400> 13
gttaattgct tgatttaaga tagacatgag gacaatcttg ttaccgacg 49
<210> 14
<211> 49
<212> DNA
<213> 人工序列
<400> 14
cgtcggtaac aagattgtcc tcatgtctat cttaaatcaa gcaattaac 49
<210> 15
<211> 43
<212> DNA
<213> 人工序列
<400> 15
cgtgaccagg atgttcattt acaaatcgtt ttcgattttc tcc 43
<210> 16
<211> 42
<212> DNA
<213> 人工序列
<400> 16
agaaaatcga aaacgatttg taaatgaaca tcctggtcac gg 42
<210> 17
<211> 45
<212> DNA
<213> 人工序列
<400> 17
gcgcagggta tttgcggtta aatgtacccg ttagggtttt tcatc 45
<210> 18
<211> 45
<212> DNA
<213> 人工序列
<400> 18
ggagaaaatc gaaaacgatt tgtaaattcc gcaaataccc tgcgc 45
<210> 19
<211> 42
<212> DNA
<213> 人工序列
<400> 19
ctatgaccat gattacgaat tctcgtcgag aatctcatcg gc 42
<210> 20
<211> 38
<212> DNA
<213> 人工序列
<400> 20
aaggagcgta tatcatgaca aaggtcagaa aagccatt 38
<210> 21
<211> 42
<212> DNA
<213> 人工序列
<400> 21
catgatatac gctccttatt tcttgacgtc cttgttcagt tg 42
<210> 22
<211> 37
<212> DNA
<213> 人工序列
<400> 22
aaggagcgta tatcatgacg ctcagtcctt tggcagg 37
<210> 23
<211> 41
<212> DNA
<213> 人工序列
<400> 23
catgatatac gctccttctt caggcaatgg cttcatcgac c 41
<210> 24
<211> 39
<212> DNA
<213> 人工序列
<400> 24
aaggagcgta tatcatgaaa aactacgcca ttatcctag 39
<210> 25
<211> 40
<212> DNA
<213> 人工序列
<400> 25
catgatatac gctccttcta ggcttgattt gggtgatgtg 40
<210> 26
<211> 35
<212> DNA
<213> 人工序列
<400> 26
aaggagcgta tatcgtgaaa atttctgtag caggc 35
<210> 27
<211> 41
<212> DNA
<213> 人工序列
<400> 27
catgatatac gctccttcta gtctcttcca aagacatctc t 41
<210> 28
<211> 39
<212> DNA
<213> 人工序列
<400> 28
aaggagcgta tatcatggga aaatattttg gaacggatg 39
<210> 29
<211> 41
<212> DNA
<213> 人工序列
<400> 29
catgatatac gctcctttta atcaaggcca atttccgcac g 41
<210> 30
<211> 39
<212> DNA
<213> 人工序列
<400> 30
aaggagcgta tatcatgtgt ggaattgttg gagttgtag 39
<210> 31
<211> 45
<212> DNA
<213> 人工序列
<400> 31
gcgcagggta tttgcggaat tttactcaac tgtaacagcc ttggc 45
<210> 32
<211> 40
<212> DNA
<213> 人工序列
<400> 32
cgacggccag tgccaagctt acagccaggt tagcagccgt 40
<210> 33
<211> 39
<212> DNA
<213> 人工序列
<400> 33
catgatatac gctccttgag gacaatcttg ttaccgacg 39
<210> 34
<211> 43
<212> DNA
<213> 人工序列
<400> 34
cgtcggtaac aagattgtcc tcaattccgc aaataccctg cgc 43
<210> 35
<211> 42
<212> DNA
<213> 人工序列
<400> 35
ctatgaccat gattacgaat tctcgtcgag aatctcatcg gc 42
<210> 36
<211> 56
<212> DNA
<213> 人工序列
<400> 36
ctcggtaccc ggggatccaa ggagcgtata tcatgactgc acttgcaatg acattg 56
<210> 37
<211> 37
<212> DNA
<213> 人工序列
<400> 37
caagcttgca tgcctgcagt caagggagtg gcgagag 37
<210> 38
<211> 43
<212> DNA
<213> 人工序列
<400> 38
ctcggtaccc ggggatccat gaaaatcgaa gaaggtaaac tgg 43
<210> 39
<211> 42
<212> DNA
<213> 人工序列
<400> 39
gcagtaaaac gaaatatcgg catagtctgc gcgtctttca gg 42
<210> 40
<211> 22
<212> DNA
<213> 人工序列
<400> 40
tttactgcac ttgcaatgac at 22
<210> 41
<211> 42
<212> DNA
<213> 人工序列
<400> 41
atgtcattgc aagtgcagta aatagtctgc gcgtctttca gg 42
<210> 42
<211> 51
<212> DNA
<213> 人工序列
<400> 42
ctcggtaccc ggggatccaa agggttcata gatgaaaatc gaagaaggta a 51
<210> 43
<211> 51
<212> DNA
<213> 人工序列
<400> 43
ctcggtaccc ggggatccaa aggagttgct tatgaaaatc gaagaaggta a 51
<210> 44
<211> 51
<212> DNA
<213> 人工序列
<400> 44
ctcggtaccc ggggatccaa aggtggttca tatgaaaatc gaagaaggta a 51
<210> 45
<211> 51
<212> DNA
<213> 人工序列
<400> 45
ctcggtaccc ggggatccaa aggggagagc catgaaaatc gaagaaggta a 51
<210> 46
<211> 51
<212> DNA
<213> 人工序列
<400> 46
ctcggtaccc ggggatccaa aggcatgttc tatgaaaatc gaagaaggta a 51
<210> 47
<211> 51
<212> DNA
<213> 人工序列
<400> 47
ctcggtaccc ggggatccaa aggcatggcc gatgaaaatc gaagaaggta a 51
<210> 48
<211> 18
<212> DNA
<213> 人工序列
<400> 48
ggatccccgg gtaccgag 18

Claims (10)

1.一种用于合成软骨素寡聚糖的重组谷氨酸棒杆菌,其特征在于,异源表达软骨素合酶从而构建软骨素的合成途径,异源表达N-乙酰葡萄糖胺差向异构酶和强化前体物质UDP-N-乙酰半乳糖胺和/或UDP-葡萄糖醛酸的合成途径的酶的表达以促进软骨素的合成,并表达软骨素裂解酶用于将软骨素裂解为软骨素寡聚糖。
2.根据权利要求1所述的一种用于合成软骨素寡聚糖的重组谷氨酸棒杆菌,其特征在于,所述软骨素合酶为(a)、(b)、(c)或(d)所示:
(a)来源于大肠杆菌(Escherichia coli K4)的软骨素合酶KfoC,或与其有60%以上同源性的酶;
(b)来源于多杀巴斯德杆菌(Pasteurella multocida)软骨素合酶pmCS,或与其有60%以上同源性的酶;
(c)含有SEQ ID NO.1和/或SEQ ID NO.2所示氨基酸序列的酶;
(d)在(a)或(b)中经过取代或缺失且具有软骨素合酶活性的由(a)或(b)衍生的蛋白质。
3.根据权利要求1所述的一种用于合成软骨素寡聚糖的重组谷氨酸棒杆菌,其特征在于,N-乙酰葡萄糖胺差向异构酶来源于大肠杆菌(E.coli K4)。
4.根据权利要求1所述的一种用于合成软骨素寡聚糖的重组谷氨酸棒杆菌,其特征在于,所述强化前体物质UDP-N-乙酰半乳糖胺和/或UDP-葡萄糖醛酸的合成途径的酶的表达包括:过表达谷氨酰胺-果糖-6-磷酸氨基转移酶、磷酸葡萄糖变位酶、UDP-N-乙酰葡萄糖胺焦磷酸化酶/葡萄糖-1-磷酸乙酰转移酶双功能酶、磷酸葡萄糖变构酶、葡萄糖-6-磷酸尿酰胺转移酶和UDP-葡萄糖脱氢酶。
5.根据权利要求1~4任一项所述的一种用于合成软骨素寡聚糖的重组谷氨酸棒杆菌,其特征在于,所述的软骨素裂解酶是动物来源或者微生物来源的任何一种能够降解软骨素分子的软骨素裂解酶。
6.根据权利要求5所述的一种用于合成软骨素寡聚糖的重组谷氨酸棒杆菌,其特征在于,软骨素裂解酶的氨基酸序列如SEQ ID NO.4所示。
7.根据权利要求6所述的一种用于合成软骨素寡聚糖的重组谷氨酸棒杆菌,其特征在于,所述的软骨素裂解酶N端融合了麦芽糖促融标签,且软骨素裂解酶N端前5个氨基酸序列进行了截短突变。
8.根据权利要求1-7任一项所述的一种用于合成软骨素寡聚糖的重组谷氨酸棒杆菌,其特征在于,将编码软骨素合酶、编码前体物质UDP-N-乙酰葡萄糖胺和UDP-葡萄糖醛酸合成途径的基因及编码软骨素裂解酶的基因与载体连接或者整合至谷氨酸棒杆菌基因组上进行表达;所述载体包括以下任一种:pXMJ19、pECXK99E、pEC-XT99A、pEKEx1、pEKEx2、pVWEx1、pVWEx2、pZ8-1、pECTAC-K99、pAPE12;基因组整合位点包括基因组上任何非必需基因位点。
9.一种生产软骨素寡聚糖的方法,其特征在于,应用权利要求1~8任一所述的重组谷氨酸棒杆菌进行发酵培养;所述发酵培养指的是在含有碳源、氮源、无机盐、金属离子和氧气的环境中,于10~45℃的条件下进行发酵培养,培养周期在8-240h之间;优选在发酵过程补料流加碳源、氮源、无机盐、金属离子等营养物质。
10.权利要求1~8任一所述重组谷氨酸棒杆菌在制备软骨素及其衍生产品方面的应用。
CN202110926226.4A 2021-08-12 2021-08-12 一种高效合成软骨素寡聚糖的重组谷氨酸棒杆菌 Active CN113684166B (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110926226.4A CN113684166B (zh) 2021-08-12 2021-08-12 一种高效合成软骨素寡聚糖的重组谷氨酸棒杆菌

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110926226.4A CN113684166B (zh) 2021-08-12 2021-08-12 一种高效合成软骨素寡聚糖的重组谷氨酸棒杆菌

Publications (2)

Publication Number Publication Date
CN113684166A true CN113684166A (zh) 2021-11-23
CN113684166B CN113684166B (zh) 2023-07-04

Family

ID=78579666

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110926226.4A Active CN113684166B (zh) 2021-08-12 2021-08-12 一种高效合成软骨素寡聚糖的重组谷氨酸棒杆菌

Country Status (1)

Country Link
CN (1) CN113684166B (zh)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107312738A (zh) * 2017-07-26 2017-11-03 江南大学 一种高效生产果糖软骨素的重组大肠杆菌及其构建方法
CN108841771A (zh) * 2018-07-11 2018-11-20 江南大学 一种产软骨素的重组谷氨酸棒杆菌及其应用
CN109486734A (zh) * 2018-10-30 2019-03-19 清华大学 一种生产软骨素的基因工程菌及其构建方法和应用

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107312738A (zh) * 2017-07-26 2017-11-03 江南大学 一种高效生产果糖软骨素的重组大肠杆菌及其构建方法
CN108841771A (zh) * 2018-07-11 2018-11-20 江南大学 一种产软骨素的重组谷氨酸棒杆菌及其应用
CN109486734A (zh) * 2018-10-30 2019-03-19 清华大学 一种生产软骨素的基因工程菌及其构建方法和应用

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
张莲: "硫酸软骨素寡糖的制备及其体外抗氧化活性研究", 中国优秀硕士学位论文全文数据库工程科技Ⅰ辑, no. 7, pages 016 - 566 *

Also Published As

Publication number Publication date
CN113684166B (zh) 2023-07-04

Similar Documents

Publication Publication Date Title
CN105087456B (zh) 一种产特定分子量透明质酸的重组枯草芽孢杆菌构建的方法
CN109486786A (zh) 一种环糊精葡萄糖基转移酶突变体
CN111518736B (zh) 一种高效合成高纯度透明质酸及其寡聚糖的重组谷氨酸棒状杆菌
CN112795606B (zh) 一种β-烟酰胺单核苷酸的酶催化合成方法
CN103468624B (zh) 一种用于高效生产海藻糖的基因工程菌
CN111548979B (zh) 合成乳酰n-新四糖的重组大肠杆菌及其构建方法与应用
CN107058200B (zh) 制备l-抗坏血酸-2-葡萄糖苷的方法
Liu et al. KfoE encodes a fructosyltransferase involved in capsular polysaccharide biosynthesis in Escherichia coli K4
CN108841771A (zh) 一种产软骨素的重组谷氨酸棒杆菌及其应用
CN112980906B (zh) 一种用于制备β-烟酰胺单核苷酸的酶组合物及其应用
CN113403245A (zh) 一种重组大肠杆菌固定化细胞及其应用
CN113684166B (zh) 一种高效合成软骨素寡聚糖的重组谷氨酸棒杆菌
CN112708569B (zh) 发酵生产硫酸软骨素的酵母工程菌及其应用
CN109456950B (zh) 一种环糊精葡萄糖基转移酶的突变体及其应用
CN106520733A (zh) 一种β‑木糖苷酶体内酶聚集体及其制备方法
WO2023035584A1 (zh) 发酵生产肝素的酵母工程菌的构建及其应用
CN113881612B (zh) 一种产肝素前体的重组大肠杆菌及其应用
CN112899248B (zh) 氨基葡萄糖-6磷酸合成酶突变体及其应用
CN111534498B (zh) 歧化比活和aa-2g产量提高的环糊精葡萄糖基转移酶突变体
CN115404226A (zh) 一种蔗糖合成酶及其在催化糖基化反应中的应用
CN113881613A (zh) 一种微生物发酵法生产制备超高分子量透明质酸的方法
CN113817704A (zh) 一种有机溶剂耐受性提高的环糊精葡萄糖基转移酶及其制备方法
CN101831397A (zh) 一种大肠杆菌和使用该大肠杆菌制备l-半胱氨酸的方法
CN117965510A (zh) 一种透明质酸酶突变体及其在制备寡聚透明质酸中的应用
CN109468298A (zh) 一种提高松二糖产量的淀粉蔗糖酶突变体

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
EE01 Entry into force of recordation of patent licensing contract

Application publication date: 20211123

Assignee: BLOOMAGE BIOTECH Co.,Ltd.

Assignor: Jiangnan University

Contract record no.: X2024980001408

Denomination of invention: A Recombinant Corynebacterium glutamicum with Efficient Synthesis of Chondroitin Oligosaccharides

Granted publication date: 20230704

License type: Exclusive License

Record date: 20240125

EE01 Entry into force of recordation of patent licensing contract